Product news from the 07/25/06 News Brief
The FDA has approved AstraZeneca’s Symbicort (budesonide/formoterol) for the maintenance treatment of asthma in patients age 12 and older. ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.